25 years we have created websites for global brands. Our success story.
Charting Our Path:
The Mission and Vision of Our Company
The Journey of iProgen
iProgen was founded with the mission to unlock new therapeutic opportunities through innovation and application of novel protein delivery technologies. Over time, our technological development and knowledge in the field of protein delivery enabled us to provide truly groundbreaking antibody discovery and development solutions to our partners pursuing bold new therapeutic programs.
Company’s Mission & Vision
Privately held, organically grown and based in Vancouver, BC.
Pioneering next-gen antibody-drug discovery using Smart Antibody™ & smart payload conjugation.
Our Smart antibody™ platform unlocks previously inaccessible targets for therapeutic development.
15+ academic and industry partnerships in diverse medical fields and expanding.
Team of Specialists
Ken Lee
Ken is a biotech entrepreneur with 25 years of experience in the field. Ken’s journey has seen him navigate through target discovery at the BC Cancer Research Center, preclinical research at Inimex Pharmaceuticals, clinical research management at BC Clinical Research, and business development roles at Helios & iProgen. He held a certification from RAPS in US Regulatory Affairs and was designated as a Clinical Research Professional by the Society of Clinical Research. Ken holds B.Sc. from UBC and MBA from the Richard Ivey School of Business.
Leo Lin
Leo brings over two decades of expertise in protein engineering and protein delivery technology, the founding scientist at iProgen has contributed immensely to our patent portfolio as a co-inventor; Leo spearheads all technological innovation at iProgen; completed post-doctoral work at Natalie Strynadka’s lab at UBC. Leo immigrated to Canada from Taiwan in his childhood and graduated with Ph.D., from McGill University with the Governor General’s Gold Medal.
Ranjani Vaidyanathan
Ranjani is a seasoned biotechnology professional with more than 16 years of industry experience in research and operational management. Her portfolio includes, but not limited to, leading internal research projects and external collaborations, patent contributions and managing and mentoring staff. Her scientific expertise includes cell line development and recombinant protein production (cGMP) and characterization, antibody and ADC assay development.
Michael J. MacLeod
Michael is a Cambridge University educated corporate lawyer, entrepreneur, investor and philanthropist. Previously, he was civil litigator at McCarthy Tetrault and Robertson, Peck, Thompson, Casilio, Vancouver. Formerly, he was also Advisor to the House of Commons Standing Committee on Transport, Ottawa.
Mike Sun
Mike brings over 20 years experience in ADC development, and is intimately familiar with GMP manufacturing of ADC for clinical development. He held various role ranging from VP of Manufacturing at Silverback Therapeutics to Sr. Director of Clinical Manufacturing at Seattle Genetics.
Jennifer Hamilton
Jennifer is a biotechnology-focused PhD scientist with 25+ years experience in working for global venture capital firms, big Pharma, and independent biotechnology companies. She was formerly Canada lead at Johnson & Johnson Innovation and Venture Partner at Nomura Phase4 Ventures.
iProgen: Pioneering Novel ADC Therapies for Unmet Medical Needs
Our technological approach opens up a wealth of possibilities for creating antibody and ADC therapies for hard-to-target receptors and conditions that current medical treatments can’t adequately address. At iProgen, we’re steering an expansive development portfolio that includes more than 10 academic collaborations and 5 industrial partnerships, with 2 preclinical stage assets primed for industry development partnership. Some of our ADC projects are the world’s first examples/application of using Antibody drug conjugate approach to treat the specific diseases.
Partnerships : Empowering Innovations through Collaboration
At iProgen, we treasure our partnerships, spanning academia and industry. These collaborations fuel our innovative streak, driving breakthroughs in oncology, immunology, and beyond.
Easy installation theme
01
Unlimited theme guide
02
Fully optimised code
03
We design brand, digital experience that engage the right customers
For creative design
Desperate for work
We love clients
Creative people
